Ictus isquémico e infección por SARS-CoV-2, ¿asociación casual o causal?
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Neurología
- Vol. 35 (5) , 295-302
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Challenges and Potential Solutions of Stroke Care During the Coronavirus Disease 2019 (COVID-19) OutbreakStroke, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemicAsian Pacific Journal of Allergy and Immunology, 2020
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2019
- Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysisLupus, 2017
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)Journal of Neurology, 2004
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993